STING1 and neoplasm: Meanwhile, STING not only participates in the immune response but also acts as a cell‐intrinsic metabolic checkpoint to limit aerobic glycolysis by targeting hexokinase 2 (HK2), thereby promoting anti‐tumor immunity in vivo [31].